- How do we design our product to meet regulatory, clinical, and commercial requirements?
- What milestones define progress from feasibility to clinical validation and commercialization?
- What studies are needed to validate product-market fit and de-risk toward launch?

Startups often address regulatory, development, clinical, and fundraising efforts in isolation. This fragmented approach leads to slower progress, inefficient spending, and weak investor narratives — ultimately causing premature exits or unnecessary founder dilution.
Without a structured systems engineering process, startups struggle to identify risks, define requirements, create validation strategies, and establish traceability from stakeholder needs to architecture and performance testing.
At Eliomedica, we leverage systems engineering principles to accelerate medical device development, minimize design errors, and ensure a smooth path to development.

We map out the R&D journey, defining milestones aligned with fundraising, regulatory and business objectives.
Copyright © 2023 ElioMedica - All Rights Reserved.